Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Absci was founded in 2011 by Sean McClain.
545 ai, data and analytics companies are in the directory, 77 of them in the same 101-250 employee range and 6 based in West Coast.
Absci reported its business updates and financial results for the fourth quarter and full year 2023. The company successfully completed an $86 million oversubscribed public offering. Absci's lead AI-designed candidate is set to head for the clinic in 2025.
“Absci is a clinical-stage biopharmaceutical company advancing innovative therapeutics with generative AI.” absci.com
Founded in 2011, Absci works in artificial intelligence (ai), biopharma and biotechnology from West Coast and has 101-250 employees. It has raised $324.3 million over 11 rounds and its website drew about 98,008 visits in the latest month measured.
11-50 employees · aiproteins.com
1-10 employees · aimetrics.com
1-10 employees · 3bigs.com
101-250 employees · adstudio.cloud
101-250 employees · aeye.ai
101-250 employees · ashita-team.com
101-250 employees · apsl.net
101-250 employees · acrolinx.com
101-250 employees · akasa.com
101-250 employees · airditsoftware.com
More in AI, data and analytics companies.
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.